Vanguard Group’s Calidi Biotherapeutics CLDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$81.3K Hold
29,448
﹤0.01% 4157
2025
Q1
$200K Buy
29,448
+24,333
+476% +$165K ﹤0.01% 4076
2024
Q4
$70.6K Buy
+5,115
New +$70.6K ﹤0.01% 4189
2024
Q3
Sell
-124
Closed -$2.99K 4353
2024
Q2
$2.99K Hold
124
﹤0.01% 4413
2024
Q1
$8.44K Buy
124
+20
+19% +$1.36K ﹤0.01% 4433
2023
Q4
$18.8K Buy
+104
New +$18.8K ﹤0.01% 4449